Exploring the COVID-19 Pandemic's Impact on the Health Technology Assessment Process of the National Commission for the Incorporation of Technologies Into the Brazilian Health System

Página do item simplificado
dc.contributor.authorCardoso, Marilia Mastrocolla de Almeida [UNESP]
dc.contributor.authorThabane, Lehana [UNESP]
dc.contributor.authorAndrade, Luis Gustavo Modelli de [UNESP]
dc.contributor.authorCurado, Daniel da Silva Pereira
dc.contributor.authorKomoda, Denis Satoshi
dc.contributor.authorMachado-Rugolo, Juliana
dc.contributor.authorLima, Silvana Andrea Molina [UNESP]
dc.contributor.authorWeber, Silke Anna Theresa [UNESP]
dc.contributor.institutionBrazil
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionMcMaster University
dc.contributor.institutionSt Joseph's Healthcare Hamilton
dc.contributor.institutionUniversity of Johannesburg
dc.contributor.institutionUniversidade Estadual de Campinas (UNICAMP)
dc.date.accessioned2023-07-29T13:55:19Z
dc.date.available2023-07-29T13:55:19Z
dc.date.issued2023-09-01
dc.description.abstractObjectives: This study aimed to evaluate the impact of the COVID-19 pandemic on Brazilian health technology assessment processes based on public reports from the National Committee for Health Technology Incorporation (CONITEC). Methods: This descriptive study analyzed CONITEC's official reports on Brazil available on its website between 2018 and 2021 that aimed to propose recommendations for technologies to be incorporated into its public healthcare system. We used descriptive statistics covering the number of technologies and number of reports about drugs per year, objective, type of technology, demanding sector, and outcome before 2018 to 2019 and during the COVID-19 pandemic (2020-2021). Furthermore, we used logistic regression to explore any association between the final decision labeled as “incorporated” and the emergence of the COVID-19 pandemic. Results: A total of 278 reports were analyzed. Approximately 85% (136 of 278), 79% (220 of 278), and 45% of the reports (125 of 278) were about drugs, for incorporation, and requested by the government, respectively. Moreover, 74 of 130 (57%) and 56 of 148 decisions (38%) were “incorporated” before and during the pandemic, respectively. No significant association was noted between incorporated decisions and the arrival of the COVID-19 pandemic for all technologies (odds ratio 1.43; 95% CI 0.84-2.46; P = .192) and for drugs (odds ratio 1.43; 95% confidence interval 0.81-2.53; P = .223) while adjusting for the type of technology and demandant. Conclusions: The COVID-19 pandemic has brought many challenges, but it does not seem to have had a significant impact on the health technology assessment approval decisions of CONITEC in Brazil.en
dc.description.affiliationHealth Technology Assessment Center Hospital das Clínicas of Medical School (HCFMB) Brazil
dc.description.affiliationGraduate Nursing Program São Paulo State University Brazil
dc.description.affiliationData Science and Predictive Analysis in Health Laboratory Hospital das Clínicas of Medical School (HCFMB) Brazil
dc.description.affiliationDepartment of Health Research Methods Evidence and Impact McMaster University
dc.description.affiliationBiostatistics Unit St Joseph's Healthcare Hamilton
dc.description.affiliationFaculty of Health Sciences University of Johannesburg
dc.description.affiliationDepartment of Internal Medicine São Paulo State University Brazil
dc.description.affiliationDepartment of Management and Incorporation of Health Technologies Ministry of Health Brazil
dc.description.affiliationDepartment of Collective Health University of Campinas Brazil
dc.description.affiliationNursing Department São Paulo State University Brazil
dc.description.affiliationDepartment of Ophthalmology Otorhinolaryngology and Head & Neck Surgery São Paulo State University Brazil
dc.description.affiliationUnespGraduate Nursing Program São Paulo State University Brazil
dc.description.affiliationUnespDepartment of Internal Medicine São Paulo State University Brazil
dc.description.affiliationUnespNursing Department São Paulo State University Brazil
dc.description.affiliationUnespDepartment of Ophthalmology Otorhinolaryngology and Head & Neck Surgery São Paulo State University Brazil
dc.format.extent18-22
dc.identifierhttp://dx.doi.org/10.1016/j.vhri.2023.04.002
dc.identifier.citationValue in Health Regional Issues, v. 37, p. 18-22.
dc.identifier.doi10.1016/j.vhri.2023.04.002
dc.identifier.issn2212-1102
dc.identifier.issn2212-1099
dc.identifier.scopus2-s2.0-85159614232
dc.identifier.urihttp://hdl.handle.net/11449/248845
dc.language.isoeng
dc.relation.ispartofValue in Health Regional Issues
dc.sourceScopus
dc.subjectBrazil
dc.subjectCOVID-19
dc.subjecthealth technology assessment
dc.subjectNational Committee for Health Technology Incorporation
dc.titleExploring the COVID-19 Pandemic's Impact on the Health Technology Assessment Process of the National Commission for the Incorporation of Technologies Into the Brazilian Health Systemen
dc.typeArtigo

Arquivos

Coleções

Artigos - Enfermagem - FMB